Lipid emulsion for parenteral administration

A lipid emulsion for parenteral administration comprising an aqueous phase and 10 to 30% of a lipid phase based on the total volume of the emulsion (w/v),

• wherein the lipid phase comprises 20 wt. % to 40 wt. % soybean oil, 20 wt. % to 40 wt. % medium-chain triglycerides, 15 wt. % to 35 wt. % olive oil, and 1-15 wt. % fish oil extract,
• wherein the lipid phase comprises less than 25 mg campesterol, less than 30 mg stigmasterol and less than 120 mg beta-sitosterol per 100 g of the lipid phase,
• wherein the lipid phase further comprises 1 to 10 wt. % arachidonic acid based on the total weight of the lipid phase,
• wherein the arachidonic acid is provided by adding a fungal oil to the lipid phase,
• wherein the lipid phase comprises 2 to 20 wt. % fungal oil based on the total weight of the lipid phase,
• wherein the fish oil extract comprises both DHA and EPA, and
• wherein said DHA is present in an amount of at least 35 wt. % and said EPA is present in an amount of less than 10 wt. % based on the total weight of the fish oil extract.